Aligos Therapeutics is a clinical-stage biotechnology company focused on developing best-in-class therapies for liver and viral diseases, particularly chronic hepatitis B virus infection and metabolic dysfunction-associated steatohepatitis (MASH)
Aligos Therapeutics is a clinical-stage biotechnology company focused on developing best-in-class therapies for liver and viral diseases, particularly chronic hepatitis B virus infection and metabolic dysfunction-associated steatohepatitis (MASH).